Stock Market Today, Jan. 22: Huntington Bancshares Falls After Missing Revenue and EPS Estimates

Huntington Bancshares shares tumbled 6.02% to $17.64 on heavy volume (86.2M, ~204% above the 3‑month average) after Q4 2025 results missed revenue and EPS estimates: revenue grew 12% but EPS dipped and both fell short of expectations. Management flagged higher expenses and credit provisions, with the criticized asset ratio rising from 3.79% to 4.23% QoQ and guided for a ~10% expense increase in 2026 tied to pending acquisitions; at the midpoint it expects stand‑alone NII and loans to rise ~11.5%, deposits 8.5% and fee revenue 14.5%, and full synergies from Vertex by Q2 and Cadence by Q4. The mix of weaker-than-expected profitability, rising credit costs and near-term expense pressure drove the selloff despite pro forma revenue and synergy potential from southern expansion.

Analysis

Market structure: Huntington’s 6% one-day drop on 204% volume signals active repricing of regional-bank execution risk — direct losers are HBAN (integration/credit risk) and acquirers carrying near-term expense loads, while competitors with cleaner balance sheets (e.g., KEY, selective national banks) can poach deposits and win market share in the South. Guidance shows NII/loans +11.5% and fees +14.5% at midpoint, so revenue momentum exists but is being offset by a guided +10% expense increase and rising criticized assets (3.79%→4.23%), reducing near-term pricing power on margins and forcing higher credit-cost expectations.

Risk assessment: Tail risks include: (1) credit deterioration pushing criticized assets >5.0% within 6–12 months, triggering regulators; (2) failed Cadence/Vertex integrations that delay synergies beyond Q4 2026 and force goodwill writedowns; (3) deposit outflows if Southern expansion misprices relationship economics. Immediate price volatility will remain elevated (days–weeks); monitor quarterly synergy confirmations at Q2 (Vertex) and Q4 (Cadence) as 3–12 month decision gates.

Trade implications: Tactical plays: express short HBAN by options to cap risk and use pair trades with stronger regionals (long KEY or FITB) to isolate Huntington-specific execution risk. Cross-asset: expect regional bank credit spreads to widen 15–40 bps near-term, raising attractiveness of buying short-dated IG bank bonds if yields reprice. Enter on continued weakness below $17 (HBAN) or if criticized assets breach 4.5%; cover if synergies announced on schedule or if HBAN reclaims $20 with volume.

Contrarian angle: The market is likely over-penalizing near-term EPS misses while undervaluing the stated revenue/loan momentum and achievable synergies — historically regionals trading through acquisition pain often mean-revert post-integration (12–24 months) if credit stays stable. A disciplined event-driven long (small size) on confirmation of Q2 synergies or deposit stabilization could capture outsized upside; conversely, persistent criticized-asset expansion argues for sustained short exposure.

Key Decisions for Investors

• Establish a defined-risk bearish position size = 2% of portfolio on HBAN via Jun-2026 16/12 put spread (buy 16 strike, sell 12 strike); open while HBAN < $18, close/roll if HBAN > $20 or criticized assets fall below 3.9% on next quarterly release.
• Implement a relative-value pair: long 2% position in KEY (buy shares) financed by short 2% HBAN (equal dollar) to capture execution dispersion over 3–6 months; unwind if KEY underperforms HBAN by >10% or if HBAN posts confirmed Q2 synergies.
• Reduce regional-bank equity exposure by 3% and reallocate to large-cap banks (e.g., JPM, BAC) by that amount to cut idiosyncratic integration risk; target a 6–12 month horizon and trim if KRE (regional ETF) outperforms broad market by >5% in a month.
• Buy a tail hedge: purchase a 6–9 month put spread on KRE (regional-bank ETF) sized at 0.5–1% of portfolio (e.g., buy 35/30 put spread) to protect against a systemic widening of regional credit spreads by >25–40 bps; close if spreads compress to pre-drop levels.